Pakistan makes final anti-dumping ruling on cefalexin from China.

On January 14, the National Tariff Commission of Pakistan issued the latest announcement of case ADC68, making a positive final ruling on anti-dumping for cefoperazone products originating from or imported from China, and deciding to impose anti-dumping duties on the products involved, as follows: The tax rate for Zhejiang Angli Kang Pharmaceutical Co., Ltd. is 8.61%, and for other Chinese producers/exporters is 11.81%. The measures will take effect from September 17, 2025, and will be valid for five years. This case involves products under Pakistan's tariff number 2941.9090, which are used to treat infections caused by bacteria, such as skin, throat, tonsils, and urinary tract infections. The products involved in the case that are used as raw materials for export or for foreign aid projects, as well as those that qualify for the tax-free plan under the Customs Act of 1969, are exempt from anti-dumping duties.